Caleres Q4 Adj EPS $0.65, Inline, Sales $696.40M Beat $689.71M Estimate

Caleres (NYSE:CAL) reported quarterly adjusted earnings of $0.65 per share which met the analyst consensus estimate. This is a 28.57 percent decrease over earnings of $0.91 per share from the same period last year. The

Caleres (NYSE:CAL) reported quarterly adjusted earnings of $0.65 per share which met the analyst consensus estimate. This is a 28.57 percent decrease over earnings of $0.91 per share from the same period last year. The company reported quarterly sales of $696.40 million which beat the analyst consensus estimate of $689.71 million by 0.97 percent. This is a 2.52 percent increase over sales of $679.28 million the same period last year.

Total
0
Shares
Related Posts
Read More

Reported Late Thursday, Geron Corporation Announces Pricing Of $198M Upsized Public Offering Of 55,876,297 Shares Of Common Stock At A Price Of $2.45/Share

Geron Corporation (NASDAQ:GERN), a late-stage clinical biopharmaceutical company, today announced the pricing of an upsized underwritten public offering consisting of 55,876,297 shares of its common stock at a public offering price of $2.45 per share and pre-funded warrants to purchase 25,000,000 shares of its com

GERN